retinal vein occlusion
Information
- Disease name
- retinal vein occlusion
- Disease ID
- DOID:1727
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05003258 | Active, not recruiting | N/A | Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients With Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection | October 7, 2021 | October 30, 2024 |
| NCT05532735 | Active, not recruiting | Phase 2 | Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion | August 24, 2022 | July 30, 2024 |
| NCT00088283 | Completed | Phase 2 | Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) | May 2004 | |
| NCT00101764 | Completed | Phase 1 | Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders | January 5, 2005 | May 20, 2008 |
| NCT00105027 | Completed | Phase 3 | The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study | October 2004 | February 2009 |
| NCT00106132 | Completed | Phase 3 | Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage | March 2005 | November 2005 |
| NCT00168298 | Completed | Phase 3 | A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion | November 1, 2004 | September 5, 2008 |
| NCT00168324 | Completed | Phase 3 | A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion | October 1, 2004 | October 1, 2008 |
| NCT00403039 | Completed | Phase 1 | Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema | November 2006 | December 2011 |
| NCT00407355 | Completed | Phase 1/Phase 2 | Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions | January 2006 | February 2013 |
| NCT00485836 | Completed | Phase 3 | A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) | July 2007 | December 2009 |
| NCT00486018 | Completed | Phase 3 | A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) | July 2007 | November 2009 |
| NCT00493064 | Completed | Phase 2/Phase 3 | To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions | October 2006 | October 2016 |
| NCT01318941 | Completed | Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting | March 2011 | April 2016 | |
| NCT00071227 | Completed | Phase 1 | Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders | October 15, 2003 | August 15, 2007 |
| NCT01377597 | Completed | Phase 3 | Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion | June 2011 | April 2012 |
| NCT01411696 | Completed | Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO) | July 2011 | March 2012 | |
| NCT01427751 | Completed | Phase 4 | Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion | October 11, 2011 | November 4, 2014 |
| NCT01428388 | Completed | N/A | Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion | September 2011 | December 2015 |
| NCT01442064 | Completed | N/A | An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) | July 2008 | July 2010 |
| NCT01449682 | Completed | Phase 3 | Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections. | October 2011 | February 2013 |
| NCT01468831 | Completed | Phase 1/Phase 2 | Minocycline to Treat Branch Retinal Vein Occlusion | March 28, 2012 | March 18, 2021 |
| NCT01468844 | Completed | Phase 1/Phase 2 | Minocycline to Treat Central Retinal Vein Occlusion | December 21, 2011 | May 13, 2015 |
| NCT01539577 | Completed | A Long-Term Safety Study of OZURDEX® in Clinical Practice | March 2012 | March 2016 | |
| NCT01566526 | Completed | Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion | March 2012 | June 2012 | |
| NCT01568021 | Completed | Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO) | October 2011 | November 2013 | |
| NCT01571557 | Completed | A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO) | April 30, 2012 | June 30, 2014 | |
| NCT01573572 | Completed | Phase 4 | Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium | April 22, 2010 | November 14, 2019 |
| NCT01580020 | Completed | Phase 4 | Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO | May 2012 | October 2014 |
| NCT01618266 | Completed | Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion | November 2011 | October 2014 | |
| NCT01662518 | Completed | Phase 1/Phase 2 | DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) | July 2011 | June 2016 |
| NCT01692938 | Completed | Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO | October 2012 | November 2012 | |
| NCT01790685 | Completed | Phase 2/Phase 3 | Ozurdex for Retinal Vein Occlusion Study (ORVO Study) | February 2013 | December 2014 |
| NCT01903720 | Completed | Phase 4 | A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion | July 16, 2013 | March 30, 2015 |
| NCT01918371 | Completed | A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema | August 2, 2013 | September 4, 2014 | |
| NCT01976650 | Completed | Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in Korea | March 2011 | March 2015 | |
| NCT02040220 | Completed | Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO) | January 24, 2014 | November 9, 2018 | |
| NCT02118831 | Completed | Phase 1/Phase 2 | Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF | March 2012 | April 2014 |
| NCT02126423 | Completed | Resistance to Antibiotics in Patients Receiving Eye Injections | May 2014 | September 2014 | |
| NCT02140411 | Completed | Phase 4 | Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. | April 25, 2015 | December 21, 2016 |
| NCT02181530 | Completed | Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX® | July 2014 | October 2014 | |
| NCT02245516 | Completed | N/A | Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema | July 2014 | December 2014 |
| NCT02303184 | Completed | Phase 2 | Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO | January 2015 | March 2016 |
| NCT02387788 | Completed | Phase 2 | Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO | January 2015 | April 2017 |
| NCT02503540 | Completed | Phase 4 | Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO | August 18, 2015 | February 6, 2018 |
| NCT02521116 | Completed | N/A | Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap | February 2016 | February 28, 2018 |
| NCT02523339 | Completed | Study of Retinal Oxygenation in Central Retinal Vein Occlusion | October 2014 | November 3, 2020 | |
| NCT02571972 | Completed | Phase 2 | Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. | February 1, 2015 | December 20, 2015 |
| NCT02614937 | Completed | Phase 1/Phase 2 | Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion | April 2013 | December 2014 |
| NCT02645747 | Completed | Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion | January 21, 2016 | December 23, 2017 | |
| NCT02880644 | Completed | Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept | January 26, 2017 | November 30, 2022 | |
| NCT02898480 | Completed | N/A | Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning | September 2016 | May 2017 |
| NCT02956330 | Completed | Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201 | November 2016 | April 12, 2017 | |
| NCT03038048 | Completed | N/A | 30g vs 33g Needle for Intravitreal Injections | January 27, 2017 | April 27, 2017 |
| NCT03093701 | Completed | Phase 2 | TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) | April 1, 2017 | February 4, 2019 |
| NCT03753893 | Completed | Ocular Manifestations in Rheumatic Diseases | May 1, 2013 | November 1, 2021 | |
| NCT03908307 | Completed | Phase 4 | Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China | July 25, 2019 | September 26, 2021 |
| NCT04395859 | Completed | Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents | May 27, 2020 | February 15, 2022 | |
| NCT04592419 | Completed | Phase 3 | A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) | September 25, 2020 | January 19, 2023 |
| NCT04635800 | Completed | Phase 1 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients | December 10, 2020 | May 24, 2022 |
| NCT04723160 | Completed | Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph | August 10, 2020 | May 30, 2021 | |
| NCT05038072 | Completed | N/A | The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion | July 25, 2019 | February 28, 2021 |
| NCT05345808 | Completed | N/A | Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions | March 1, 2021 | March 30, 2022 |
| NCT06176963 | Completed | Phase 2 | A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO | November 21, 2023 | December 12, 2023 |
| NCT06213896 | Completed | Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images | March 1, 2023 | April 18, 2024 | |
| NCT06416241 | Completed | Phase 4 | Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion | January 1, 2017 | March 31, 2024 |
| NCT00636493 | Completed | Early Phase 1 | Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO) | October 2002 | May 2009 |
| NCT00804102 | Completed | N/A | Transcorneal Electrical Stimulation Therapy for Retinal Disease | January 2008 | April 2011 |
| NCT00805064 | Completed | Phase 3 | Combined Triple Procedure in Retinal Vein Occlusion (RVO) | January 2006 | November 2008 |
| NCT00831350 | Completed | Phase 2 | Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations | April 2009 | December 2012 |
| NCT00942864 | Completed | Phase 3 | Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) | December 2008 | December 2009 |
| NCT00970957 | Completed | Phase 3 | Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion | September 2009 | February 2013 |
| NCT01003106 | Completed | Phase 1/Phase 2 | Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions | November 2009 | April 2015 |
| NCT01012973 | Completed | Phase 3 | Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) | October 2009 | February 2012 |
| NCT01027481 | Completed | Phase 4 | Ranibizumab in Patients With Branch Retinal Vein Occlusion | December 2007 | December 2009 |
| NCT01027650 | Completed | Phase 1/Phase 2 | Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO) | March 2010 | February 2013 |
| NCT01198327 | Completed | Phase 3 | Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion | August 2010 | December 2012 |
| NCT00000131 | Completed | Phase 3 | Central Vein Occlusion Study (CVOS) | August 1988 | February 1994 |
| NCT05675540 | Not yet recruiting | Artificial Intelligence Diagnostic Aid | June 1, 2023 | March 30, 2024 | |
| NCT04008121 | Not yet recruiting | Early Phase 1 | Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium | April 2024 | July 2024 |
| NCT06343961 | Not yet recruiting | N/A | Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy | April 18, 2024 | December 2025 |
| NCT05099094 | Recruiting | Early Phase 1 | VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases | November 25, 2021 | September 2023 |
| NCT05130385 | Recruiting | High Resolution Optical Coherence Tomography | November 30, 2021 | November 30, 2023 | |
| NCT05133791 | Recruiting | Phase 1 | NIR Fluorescence Molecular Imaging of ANXV-800CW in RVO Patients | September 23, 2021 | May 1, 2024 |
| NCT01496625 | Recruiting | National Eye Institute Biorepository for Retinal Diseases | June 18, 2012 | ||
| NCT05532475 | Recruiting | Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion | March 12, 2022 | October 2022 | |
| NCT04505618 | Recruiting | N/A | Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease | October 1, 2019 | September 1, 2025 |
| NCT05496530 | Recruiting | N/A | Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results) | July 10, 2022 | August 15, 2023 |
| NCT06439576 | Recruiting | Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study) | May 9, 2024 | November 30, 2027 | |
| NCT03680794 | Recruiting | N/A | Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies | June 27, 2018 | February 1, 2025 |
| NCT04075695 | Recruiting | Ultra-wide-field Fluorescein Angiography in Patients With Retinal Vein Occlusion | September 18, 2019 | August 12, 2025 | |
| NCT06332690 | Recruiting | OCT and OCT-Angiography Biomarkers of Treatment Response to Dexamethasone Implant in Macular Edema Due to Retinal Vascular Diseases - DME and RVO | October 17, 2023 | December 2025 | |
| NCT04140448 | Recruiting | Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion | October 9, 2023 | December 15, 2025 | |
| NCT06262737 | Recruiting | Single-center Study Measuring OSDI Dry Eye Score in Patients Undergoing an Anti-VEGF Induction Protocol | September 30, 2023 | October 1, 2025 | |
| NCT04707625 | Terminated | Phase 4 | Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment | October 6, 2021 | December 18, 2023 |
| NCT00732927 | Terminated | Phase 3 | Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion | July 2002 | September 2007 |
| NCT00770770 | Terminated | Phase 2 | Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina | May 2009 | |
| NCT04563299 | Terminated | Phase 4 | Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections | December 9, 2020 | February 14, 2023 |
| NCT02510885 | Terminated | N/A | SD-OCT Angiography | July 2015 | March 11, 2019 |
| NCT01225146 | Terminated | Phase 1 | Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2) | October 2010 | August 2012 |
| NCT00379223 | Terminated | N/A | Radial Optic Neurotomy in Central Retinal Vein Occlusion : a Randomized Trial | October 2006 | September 2008 |
| NCT02980874 | Terminated | Phase 3 | Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO | January 31, 2017 | December 10, 2018 |
| NCT03203447 | Terminated | Phase 3 | Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO | March 5, 2018 | December 18, 2018 |
| NCT03790852 | Terminated | Phase 1 | Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO | December 26, 2018 | June 9, 2022 |
| NCT01717937 | Terminated | Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging | February 2013 | June 2013 | |
| NCT01875770 | Terminated | Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE) | January 2013 | March 3, 2021 | |
| NCT02088151 | Terminated | N/A | Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina | June 2010 | February 1, 2022 |
| NCT04062370 | Unknown status | Phase 4 | Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion | October 1, 2019 | August 31, 2022 |
| NCT03489915 | Unknown status | Correlation Between the Visual Acuity & the OCT Pattern of Macular Edema Secondary to RVO | May 1, 2018 | May 2020 | |
| NCT03525132 | Unknown status | N/A | Study of the Retinal Vascularization by Laser Doppler Velocimetry Coupled With an Adaptive Optics Camera ( AO-LDV) | September 18, 2015 | September 18, 2020 |
| NCT01123564 | Unknown status | Phase 2 | Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion | August 2009 | September 2011 |
| NCT01581151 | Unknown status | N/A | Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion | September 2011 | June 2015 |
| NCT00517257 | Unknown status | Phase 3 | Atorvastatin for the Treatment of Retinal Vein Occlusion | August 2007 | September 2009 |
| NCT01635803 | Unknown status | Phase 2/Phase 3 | Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO) | June 2012 | |
| NCT03762226 | Unknown status | Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA Study | September 1, 2018 | December 31, 2021 | |
| NCT04142164 | Unknown status | N/A | Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections | October 24, 2019 | January 1, 2024 |
| NCT02257333 | Unknown status | Retinal Thrombosis and Atherosclerosis | September 1, 2015 | September 2020 | |
| NCT01011374 | Unknown status | Phase 1 | Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion | November 2009 | November 2013 |
| NCT01809236 | Unknown status | Phase 2 | Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion | May 2012 | March 2014 |
| NCT01857544 | Unknown status | Phase 4 | Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy | June 2013 | March 2016 |
| NCT04847869 | Unknown status | N/A | Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema | January 1, 2021 | July 31, 2022 |
| NCT03391219 | Unknown status | Phase 2/Phase 3 | Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients | January 2018 | October 2018 |
| NCT03918590 | Unknown status | Phase 4 | Post Intravitreal Injection Topical NSAID vs. Patching | December 3, 2018 | June 3, 2019 |
| NCT02486484 | Unknown status | Phase 2 | Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection | March 2015 | December 2019 |
| NCT03056079 | Unknown status | Phase 4 | Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept | February 28, 2017 | February 28, 2024 |
| NCT03056092 | Unknown status | Phase 4 | Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab | February 28, 2017 | February 28, 2024 |
| NCT05222633 | Unknown status | Anti-VEGF in Real-world | January 1, 2022 | May 1, 2023 | |
| NCT00211354 | Withdrawn | Phase 2 | Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.) | March 2002 | April 2007 |
| NCT04011358 | Withdrawn | N/A | Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study | September 2021 | September 2022 |
- Disase is a (Disease Ontology)
- DOID:1729
- Cross Reference ID (Disease Ontology)
- MESH:D012170
- Cross Reference ID (Disease Ontology)
- NCI:C34981
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:46085004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0035328
- Exact Synonym (Disease Ontology)
- Occlusion, of retinal vein
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0012636
- MedGen concept unique identifier (MedGen Concept name)
- C0035328
- MedGen unique identifier (MedGen Concept name)
- 19763
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012170